GKA APEA Pharm- Women's Health Exam | Most Recent Exam 2026
Actual Complete Real Exam Questions And Correct Answers
(Verified Answers) Already Graded A+ |Guaranteed Success!!
Newest Exam | Just Released!!
Which of the following would NOT be an appropriate choice for the treatment of
primary dysmenorrhea in an 18-year-old woman?
Nonsteroidal anti-inflammatory medications
Oral contraceptives
Vitamin B6
Intrauterine devices
Intrauterine devices
all other 3 are first line IUD
= last resort
A 23-year-old woman with a desire for pregnancy needs treatment for symptoms related to
polycystic ovarian syndrome (PCOS). The initial choice is:
liraglutide (Victoza).
metformin (Glucophage).
spironolactone (Aldactone).
finasteride (Proscar).
metformin (Glucophage).
Spironolactone and finasteride are second-line therapy options.
Victoza is not indicated in the treatment of PCOS.
,For treatment of menopausal symptoms in a woman with a history of hormone-
sensitive breast cancer, the nurse practitioner should consider:
androgen therapy.
gonadotropin-releasing hormone analogs.
selective serotonin reuptake inhibitors.
progesterone-only therapy.
selective serotonin reuptake inhibitors.
Nonhormonal treatments for menopausal symptoms include:
benzodiazepines.
copper intrauterine device.
selective serotonin reuptake inhibitors.
antiepileptic/antiseizure medications.
selective serotonin reuptake inhibitors.
Which of the following is NOT true about the administration of
medroxyprogesterone acetate (Depo-Provera)?
Few drug-drug interactions are associated with intramuscular Depo-Provera
compared to oral contraceptives.
Depo-Provera must be discontinued and an alternate contraceptive considered at least
6 months before attempting pregnancy.
Menses may not return for 3 to 12 months after the last Depo-Provera injection. Patients
should be advised to take calcium and vitamin D while taking Depo-Provera.
Few drug-drug interactions are associated with intramuscular Depo-Provera
compared to oral contraceptives.
, In addition to inhibiting ovulation, combined contraceptives further prevent
pregnancy by:
creating a toxic environment for sperm.
increasing the viscosity of cervical mucus.
decreasing production of sex hormone-binding globulin.
thinning the uterine wall.
increasing the viscosity of cervical mucus.
Combined oral contraceptives are NOT likely to cause:
thromboembolism.
hypertension.
gallbladder disease.
ovarian cysts.
ovarian cysts.
Combined contraceptives, whether oral, patch or intravaginal, work in the ovulatory phase
by:
increasing follicle-stimulating hormone and luteinizing hormone.
decreasing follicle-stimulating hormone and increasing luteinizing hormone.
suppressing follicle-stimulating hormone and luteinizing hormones.
increasing the release of follicle-stimulating hormone and luteinizing hormone.
suppressing follicle-stimulating hormone and luteinizing hormones.
Actual Complete Real Exam Questions And Correct Answers
(Verified Answers) Already Graded A+ |Guaranteed Success!!
Newest Exam | Just Released!!
Which of the following would NOT be an appropriate choice for the treatment of
primary dysmenorrhea in an 18-year-old woman?
Nonsteroidal anti-inflammatory medications
Oral contraceptives
Vitamin B6
Intrauterine devices
Intrauterine devices
all other 3 are first line IUD
= last resort
A 23-year-old woman with a desire for pregnancy needs treatment for symptoms related to
polycystic ovarian syndrome (PCOS). The initial choice is:
liraglutide (Victoza).
metformin (Glucophage).
spironolactone (Aldactone).
finasteride (Proscar).
metformin (Glucophage).
Spironolactone and finasteride are second-line therapy options.
Victoza is not indicated in the treatment of PCOS.
,For treatment of menopausal symptoms in a woman with a history of hormone-
sensitive breast cancer, the nurse practitioner should consider:
androgen therapy.
gonadotropin-releasing hormone analogs.
selective serotonin reuptake inhibitors.
progesterone-only therapy.
selective serotonin reuptake inhibitors.
Nonhormonal treatments for menopausal symptoms include:
benzodiazepines.
copper intrauterine device.
selective serotonin reuptake inhibitors.
antiepileptic/antiseizure medications.
selective serotonin reuptake inhibitors.
Which of the following is NOT true about the administration of
medroxyprogesterone acetate (Depo-Provera)?
Few drug-drug interactions are associated with intramuscular Depo-Provera
compared to oral contraceptives.
Depo-Provera must be discontinued and an alternate contraceptive considered at least
6 months before attempting pregnancy.
Menses may not return for 3 to 12 months after the last Depo-Provera injection. Patients
should be advised to take calcium and vitamin D while taking Depo-Provera.
Few drug-drug interactions are associated with intramuscular Depo-Provera
compared to oral contraceptives.
, In addition to inhibiting ovulation, combined contraceptives further prevent
pregnancy by:
creating a toxic environment for sperm.
increasing the viscosity of cervical mucus.
decreasing production of sex hormone-binding globulin.
thinning the uterine wall.
increasing the viscosity of cervical mucus.
Combined oral contraceptives are NOT likely to cause:
thromboembolism.
hypertension.
gallbladder disease.
ovarian cysts.
ovarian cysts.
Combined contraceptives, whether oral, patch or intravaginal, work in the ovulatory phase
by:
increasing follicle-stimulating hormone and luteinizing hormone.
decreasing follicle-stimulating hormone and increasing luteinizing hormone.
suppressing follicle-stimulating hormone and luteinizing hormones.
increasing the release of follicle-stimulating hormone and luteinizing hormone.
suppressing follicle-stimulating hormone and luteinizing hormones.
